Sunlight vs Oak Longevity: Pricing, meds, and service compared
Sunlight vs Oak Longevity: which telehealth GLP-1 option fits you? Quick verdict: Sunlight advertises lower starting prices and a “same price forever” promise, while Oak Longevity advertises flat pricing by drug, free health coaching, and compounded options at semaglutide $133/mo and tirzepatide $199/mo.
Start Sunlight plan from $88/mo
How pricing and price structure differ
Sunlight: Personalized GLP-1 from $88/mo and marketing states “Same price forever” and “No price increases ever, no hidden fees.” Oak Longevity: semaglutide from $133/month and tirzepatide from $199/month with “one price covers all dosages” and billed monthly on a non-recurring basis. Oak notes three-month prescriptions are billed upfront and no refunds after physician approval and shipping.
See Oak Longevity semaglutide from $133/mo
Medications offered and formulation differences
Sunlight offers “injections & oral options” and describes “personalized GLP-1” plans. Oak Longevity offers compounded semaglutide and compounded tirzepatide and explicitly states compounded medications are not FDA-approved finished products and are not reviewed by FDA for safety, effectiveness or quality.
Clinical review, enrollment flow, and support
Sunlight emphasizes a 100% online medical visit with prescription and telehealth included and highlights clinician adjustments and support in testimonials. Oak Longevity runs an online questionnaire with a licensed physician review that can be asynchronous; Oak says no video call is required and that board-certified physicians in your state review every case.
Shipping, membership, and refund policies
Sunlight marketing says free shipping in 1-2 days, “Fast, Free Shipping,” no monthly membership, and “Cancel Anytime” with claims of free discreet 2-day shipping in some copy. Oak Longevity advertises free shipping with tracking, free health coaching, no subscriptions or membership fees, and that most patients receive medication within a few days of approval. Oak also states no refunds are available after physician approval and once medication has shipped.
Comparison table
| Criteria | Sunlight | Oak Longevity |
|---|---|---|
| Starting price | $88/mo (personalized GLP-1, “as low as” phrasing) | Semaglutide $133/mo; Tirzepatide $199/mo |
| Price structure | “Same price forever” claim, no price increases stated | One flat price covers all dosages; non-recurring monthly billing |
| Medication format | Injections and oral options available | Compounded semaglutide and tirzepatide (not FDA-approved finished products) |
| Clinical process | 100% online medical visit; telehealth included | Online questionnaire with licensed physician review; no video call required |
| Shipping & fees | Fast, free shipping; free discreet 2-day shipping in landing copy | Free shipping with tracking; three-month prescriptions billed upfront |
| Refunds & cancellations | Cancel anytime; marketing claims of no hidden fees | No refunds after physician approval and shipping; billed non-recurring monthly |
Three key differences to consider
1. Price entry point and messaging
If starting price is decisive, Sunlight advertises plans starting at $88/mo and highlights a “same price forever” message. Oak lists specific drug starting prices: semaglutide $133/mo and tirzepatide $199/mo and emphasizes one flat price for all dosages.
2. Compounded product vs branded-language options
Oak Longevity explicitly offers compounded semaglutide and tirzepatide and warns these compounded medications are not FDA-approved finished products. Sunlight does not present compounded language in the captured evidence and instead emphasizes injections and oral options plus prescription and telehealth.
3. Billing cadence and refunds
Oak advertises non-recurring monthly billing and notes three-month prescriptions are billed upfront with no refunds after physician approval and shipment. Sunlight marketing highlights “no monthly membership,” “cancel anytime,” and “same price every month” but captured evidence warns pricing, eligibility, pharmacy, state coverage and renewal terms may change.
Compare Sunlight plans and start enrollment
Safety, eligibility, and regulatory notes
Oak Longevity: captured evidence states compounded medications are not FDA-approved and treatment is available only when a licensed clinician determines it is medically appropriate. Sunlight: captured regulatory note says medication-specific approval status must be confirmed; branded and compounded products are not interchangeable. Both providers instruct clinical review determines eligibility in their messaging.
Start Sunlight eligibility check
Bottom line: Sunlight vs Oak Longevity
Sunlight vs Oak Longevity centers on price structure, formulations, and billing. Sunlight advertises a lower starting price from $88/mo, injections and oral options, and a “same price forever” message. Oak Longevity advertises semaglutide from $133/mo and tirzepatide from $199/mo, one flat price for all dosages, free health coaching, and compounded formulations that are not FDA-reviewed. Choose based on which tradeoffs matter: list price and a same-price claim with Sunlight, or Oak’s flat dosing price, free coaching, and compounded options with their stated refund and billing terms.
Choose Sunlight if you prioritize a lower advertised starting price from $88/mo, injections and oral options, and marketing about no price increases and simple online telehealth.
Choose Oak Longevity if you want one flat price per drug for all dosages, free health coaching and free shipping, and are comfortable with compounded formulations and Oak’s billing and refund terms.